The rapid advancements in the digital health sector are affecting all aspects of the pharmaceutical industry and require a better understanding of the investments and partnerships needed to drive innovation and progress.
To better understand the complexities of applying digital technologies that maximize the potential to transform every aspect of the pharmaceutical value chain, Pharma Intelligence and EBD Group consolidated industry insights into a downloadable article pack.
What’s Inside:
- Pharma deal-making for AI and machine learning
- Problems medtech innovators should focus on
- The “do’s and don’ts” when talking to potential investors
- Being proactive in clinical development using digital technologies
- How successful manufacturers are seeking to enhance value